News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ZymoGenetics, Inc. (ZGEN) (JOBS) Says Merck Serono Discontinues MS Trials


9/28/2009 6:27:01 AM

Bookmark and Share

Reuters -- Biotechnology firm Zymogenetics Inc said its licensee, Merck Serono SA, discontinued trials of its experimental drug, atacicept, for the treatment of multiple sclerosis (MS).

Read at Reuters
Read at Xconomy


comments powered by Disqus
Reuters
Xconomy
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES